Biogen Idec 2011 total revenues increase 7% to $5.0 billion

Posted in News

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its full year and fourth quarter 2011 results.

Tags: Biogen, Biogen Idec, Biogen Idec Inc, Commercialization, Discovery, Fourth Quarter, Global Biotechnology, Innovative Therapies, Revenues Increase